FDA expresses major concerns over the safety of transvaginal placement of surgical mesh
In a recent FDA Safety Communication, the Food and Drug Administration updated the public on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse.
OsmoPrep and the two different types of kidney failure
OsmoPrep was licensed in 2006 by the FDA, and then in 2008 a box warning …
OsmoPrep and kidney failure linked
OsmoPrep is a product used before a colonoscopy. It was licensed in 2006 by the US Food and Drug Administration. Basically the drug allows doctors to get a better view of the colon by inducing loose bowels. Two years after OsmoPrep was approved, the FDA publicly announced the addition of a black box warning of kidney damage to the labeling of these products.
Call us at 1-800-810-3457 if you took OsmoPrep and developed kidney failure.
Woman petitions FDA to remove OsmoPrep from the market
OsmoPrep is a product used before a colonoscopy. It was licensed in 2006 by the US Food and Drug Administration. Basically the drug allows doctors to get a better view of the colon by inducing loose bowels. Two years after OsmoPrep was approved, the FDA publicly announced the addition of a black box warning of kidney damage to the labeling of these products.
Call us at 1-800-810-3457 if you took OsmoPrep and developed kidney problems.
Crestor Damages Heart Muscle, Liver And Kidneys
Crestor is approved to lower cholesterol and triglycerides in combination with diet and exercise in patients with high cholesterol and/or triglycerides, to slow the progression of atherosclerosis, and for the primary prevention of cardiovascular disease to reduce the risk of stroke, heart attack, and the risk of arterial revascularization procedures.
Crestor is known to increase the risk of developing muscle damage. SInce your heart is a muscle, there is a risk that Crestor can cause damage to your heart. Cardiomyopathy is a disease that weakens and enlarges your heart muscle. Cardiomyopathy makes it harder for your heart to pump blood and deliver it to the rest of your body.
Crestor linked to muscle damage
Statins are the most widely used medications to lower “bad” (LDL) cholesterol in order to prevent heart attacks and strokes. Statins work by blocking a substance your body needs to make cholesterol. Statins may also help your body reabsorb cholesterol that has built up in plaques on your artery walls, preventing further blockage in your blood vessels and heart attacks.
Actos Side Effects Include Bladder Cancer
People who take Actos for over a year are an increased risk of developing bladder cancer says FDA.
Actos is a prescription medication used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. It works on two of the common problems that lead to high blood sugar in type 2 diabetes. First by helping your body better use the insulin it makes, and secondly it also stops your liver from making more sugar when it doesn’t need to. Other Actos side effects include congestive heart failure.
If you or a loved one developed Actos bladder cancer call the Law Offices of Sadaka Associates today!
Despite Bladder Cancer Risk, American Diabetes Association Recommends Patients Continue Treatment
Bladder cancer risks aren’t likely to send the diabetes drug pioglitazone (Actos) down the same path as rosiglitazone (Avandia), according to an exclusive InFocus report from the American Diabetes Association meeting.
Zimmer hip and knee implant failure
In July 2008, Zimmer Holdings announced it was suspending sales of the Durom Cup hip implant component due to a high number of patient complaints.
The Durom Cup has been implanted in over 12,000 patients since it was first sold in the United States in 2006. The Durom Cup was designed for use in young, active patients who are likely to outlive a conventional hip prosthesis. Unfortunately, patients receiving this defective device often experienced crippling pain following surgery, leaving them more disabled than they had been before their hip replacement.
FDA issues safety announcement concerning risk of cancer with osteoporosis drugs
On July 21, 2011 the FDA issued a safety announcement concerning their ongoing investigation of …
National Vaccine Injury Compensation Program
Vaccines are a very controversial topic. Do you get them or not? What about the …
FDA plans new study for DTC promoting
On April 28, 2011, The Food and Drug Administration (FDA) announced plans to study online …
Birth control pills with drospirenone raise clot risk
Probably every woman has heard the risk for developing blood clots if she takes birth …
FDA has a new plan to fight against misuse of Opioid’s
An article found on the FDA website dated April 19, 2011, states that The toll …